Literature DB >> 19389803

Molecular and functional characterization of Kv7 K+ channel in murine gastrointestinal smooth muscles.

Thomas A Jepps1, Iain A Greenwood, James D Moffatt, Kenton M Sanders, Susumu Ohya.   

Abstract

Members of the K(v)7 voltage-gated K(+) channel family are important determinants of cardiac and neuronal membrane excitability. Recently, we and others have shown that K(v)7 channels are also crucial regulators of smooth muscle activity. The aim of the present study was to assess the K(v)7 expression in different parts of the murine gastrointestinal (GI) tract and to assess their functional roles by use of pharmacological agents. Of KCNQ/K(v)7 members, both KCNQ4/K(v)7.4 and KCNQ5/K(v)7.5 genes and proteins were the most abundantly expressed K(v)7 channels in smooth muscles throughout the GI tract. Immunohistochemical staining also revealed that K(v)7.4 and K(v)7.5 but not K(v)7.1 were expressed in the circular muscle layer of the colon. In segments of distal colon circular muscle exhibiting spontaneous phasic contractions, the nonselective K(v)7 blockers XE991 and linopirdine increased the integral of tension. Increases in the integral of tension were also observed under conditions of neuronal blockade. Similar effects, although less marked, were observed in the proximal colon. As expected, the K(v)7.1-selective blocker chromanol 293B had no effect in either type of segment. These data show that K(v)7.x especially K(v)7.4 and K(v)7.5 are expressed in different regions of the murine gastrointestinal tract and blockers of K(v)7 channels augment inherent contractile activity. Drugs that selectively block K(v)7.4/7.5 might be promising therapeutics for the treatment of motility disorders such as constipation associated with irritable bowel syndrome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19389803      PMCID: PMC2711751          DOI: 10.1152/ajpgi.00057.2009

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  50 in total

Review 1.  Involvement of intramuscular interstitial cells of Cajal in neuroeffector transmission in the gastrointestinal tract.

Authors:  Sean M Ward; Kenton M Sanders
Journal:  J Physiol       Date:  2006-09-14       Impact factor: 5.182

2.  Differential gene expression in functional classes of interstitial cells of Cajal in murine small intestine.

Authors:  Hui Chen; Tamás Ordög; Junwei Chen; David L Young; Michael R Bardsley; Doug Redelman; Sean M Ward; Kenton M Sanders
Journal:  Physiol Genomics       Date:  2007-09-25       Impact factor: 3.107

3.  Expression profile and characterisation of a truncated KCNQ5 splice variant.

Authors:  Shuk Yin M Yeung; Wienke Lange; Michael Schwake; Iain A Greenwood
Journal:  Biochem Biophys Res Commun       Date:  2008-05-05       Impact factor: 3.575

Review 4.  New tricks for old dogs: KCNQ expression and role in smooth muscle.

Authors:  Iain A Greenwood; Susumu Ohya
Journal:  Br J Pharmacol       Date:  2009-04       Impact factor: 8.739

5.  Cloning and characterization of a Kv1.5 delayed rectifier K+ channel from vascular and visceral smooth muscles.

Authors:  K E Overturf; S N Russell; A Carl; F Vogalis; P J Hart; J R Hume; K M Sanders; B Horowitz
Journal:  Am J Physiol       Date:  1994-11

6.  Vasopressin stimulates action potential firing by protein kinase C-dependent inhibition of KCNQ5 in A7r5 rat aortic smooth muscle cells.

Authors:  Lioubov I Brueggemann; Christopher J Moran; John A Barakat; Jay Z Yeh; Leanne L Cribbs; Kenneth L Byron
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-10-27       Impact factor: 4.733

7.  Vascular KCNQ potassium channels as novel targets for the control of mesenteric artery constriction by vasopressin, based on studies in single cells, pressurized arteries, and in vivo measurements of mesenteric vascular resistance.

Authors:  Alexander R Mackie; Lioubov I Brueggemann; Kyle K Henderson; Aaron J Shiels; Leanne L Cribbs; Karie E Scrogin; Kenneth L Byron
Journal:  J Pharmacol Exp Ther       Date:  2008-02-13       Impact factor: 4.030

8.  Expression and function of K(v)7 channels in murine myometrium throughout oestrous cycle.

Authors:  Laura A McCallum; Iain A Greenwood; Rachel M Tribe
Journal:  Pflugers Arch       Date:  2008-08-16       Impact factor: 3.657

9.  Bimodal effects of the Kv7 channel activator retigabine on vascular K+ currents.

Authors:  Sym Yeung; M Schwake; V Pucovský; Ia Greenwood
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

10.  Molecular expression and pharmacological identification of a role for K(v)7 channels in murine vascular reactivity.

Authors:  S Y M Yeung; V Pucovský; J D Moffatt; L Saldanha; M Schwake; S Ohya; I A Greenwood
Journal:  Br J Pharmacol       Date:  2007-05-21       Impact factor: 8.739

View more
  35 in total

1.  Kv7 potassium channels in airway smooth muscle cells: signal transduction intermediates and pharmacological targets for bronchodilator therapy.

Authors:  Lioubov I Brueggemann; Priyanka P Kakad; Robert B Love; Julian Solway; Maria L Dowell; Leanne L Cribbs; Kenneth L Byron
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-30       Impact factor: 5.464

2.  Expression and function of the K+ channel KCNQ genes in human arteries.

Authors:  Fu Liang Ng; Alison J Davis; Thomas A Jepps; Maksym I Harhun; Shuk Yin Yeung; Andrew Wan; Marcus Reddy; David Melville; Antonio Nardi; Teck K Khong; Iain A Greenwood
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

Review 3.  Ionic conductances regulating the excitability of colonic smooth muscles.

Authors:  Sang Don Koh; S M Ward; K M Sanders
Journal:  Neurogastroenterol Motil       Date:  2012-06-24       Impact factor: 3.598

4.  KV7 Channel Pharmacological Activation by the Novel Activator ML213: Role for Heteromeric KV7.4/KV7.5 Channels in Guinea Pig Detrusor Smooth Muscle Function.

Authors:  Aaron Provence; Damiano Angoli; Georgi V Petkov
Journal:  J Pharmacol Exp Ther       Date:  2017-10-30       Impact factor: 4.030

5.  Branched Short-Chain Fatty Acid Isovaleric Acid Causes Colonic Smooth Muscle Relaxation via cAMP/PKA Pathway.

Authors:  Bryan A Blakeney; Molly S Crowe; Sunila Mahavadi; Karnam S Murthy; John R Grider
Journal:  Dig Dis Sci       Date:  2018-12-17       Impact factor: 3.199

6.  Participation of KCNQ (Kv7) potassium channels in myogenic control of cerebral arterial diameter.

Authors:  Xi Zoë Zhong; Maksym I Harhun; Soren P Olesen; Susumu Ohya; James D Moffatt; William C Cole; Iain A Greenwood
Journal:  J Physiol       Date:  2010-07-12       Impact factor: 5.182

7.  Vasorelaxant effects of novel Kv 7.4 channel enhancers ML213 and NS15370.

Authors:  T A Jepps; B H Bentzen; J B Stott; O V Povstyan; K Sivaloganathan; W Dalby-Brown; I A Greenwood
Journal:  Br J Pharmacol       Date:  2014-08-14       Impact factor: 8.739

8.  KCNQ5 activation is a unifying molecular mechanism shared by genetically and culturally diverse botanical hypotensive folk medicines.

Authors:  Rían W Manville; Jennifer van der Horst; Kaitlyn E Redford; Benjamin B Katz; Thomas A Jepps; Geoffrey W Abbott
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-30       Impact factor: 11.205

9.  Differential protein kinase C-dependent modulation of Kv7.4 and Kv7.5 subunits of vascular Kv7 channels.

Authors:  Lioubov I Brueggemann; Alexander R Mackie; Leanne L Cribbs; Jessica Freda; Abhishek Tripathi; Matthias Majetschak; Kenneth L Byron
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

Review 10.  One man's side effect is another man's therapeutic opportunity: targeting Kv7 channels in smooth muscle disorders.

Authors:  T A Jepps; S P Olesen; I A Greenwood
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.